The M. Pharm (Pharmaceutics) and M. Pharm (Pharmaceutical Technology) Programs lead to specialization in formulation development, manufacturing technology, and process development areas, which are essential specializations for manufacturing of traditional and novel drug delivery systems.
The first year involves theoretical and practical sessions in the following areas: dosage form design; advanced pharmaceutical methods of analysis; drug regulatory affairs; biopharmaceutics and pharmacokinetics; dosage form technology; advances in industrial pharmacy; and novel drug delivery systems.
The second-year projects touch upon formulation development, stability studies, and process validation for traditional and novel drug delivery systems.
Some of the areas that have been taken-up by various batches since 2009 include hydrogels, microemulsions, microspheres, nanospheres, nanosuspensions, gastroretentive systems, solid-solid and solid-liquid dispersed systems, and development of modified accipients.
Continuous interaction with industries including Nectar life Sciences, Abbott Healthcare, Unichem, Jubilant Clinsys, Arbro Pharma, Dr Reddys Labs and other organizations for academic, conferences and placements is a special feature during the course.
This Program leads to specialization in pharmacology, which is an integral part of the drug discovery and drug design processes. These processes deal with the identification of lead molecules that could have potential therapeutic activity due to specific molecular and receptor affinity, and analogous structure to specific sites and proteins in the body.
In the first year the Program covers theoretical and practical sessions in the subjects molecular pharmacology; general pathophysiology; pharmacology and pharmacotherapeutics I and II; clinical research methodologies; advanced pharmaceutical methods of analysis; drug regulatory affairs; quality assurance and biostatistics; and other subjects.
In the second year of the Program students take-up several projects that are aimed at developing and exploring novel receptor targets, and mechanisms for drug action in the pathophysiological stages of the disease.
(Clinical Research and Clinical Pharmacology Branch)
This Program offers a specialization in the clinical drug development methodologies, its regulations, and control. Once the safety and efficacy of a novel chemical entity is established for a drug compound in preclinical animal studies, it is put through the process of clinical development. This is where the drug is studied for safety, efficacy and dosing in increasing numbers of human population setting through Phase I–IV clinical trials. The branch offers exposure to subjects on principles of pharmacology and therapeutics; clinical research methodologies; clinical DRUG development; advanced pharmaceutical methods of analysis; drug regulatory affairs; recent advances in pharmacology; quality assurance and biostatistics; and other subjects.
The second-year clinical projects are done in hospital inpatient /outpatient Settings either in association with a clinical research organization or a pharmaceutical company. The College has memoranda of association in place for the same with:
